Imaging of tumour response to immunotherapy

Por Dromain, Clarisse, Beigelman, Catherine, Pozzessere, Chiara, Duran, Rafael, Digklia, Antonia
Publicado no Eur Radiol Exp (2020)

Contamination Artifact that Mimics In-situ Carcinoma on Contrast-Enhanced Digital Mammography

Por Gluskin, Jill, Click, Michael, Fleischman, Richard, Dromain, Clarisse, Morris, Elizabeth A, Jochelson, Maxine
Publicado no Eur J Radiol (2017)

Novel Tumor Growth Rate Analysis in the Randomized CLARINET Study Establishes the Efficacy of Lanreotide Depot/Autogel 120 mg with Prolonged Administration in Indolent Neuroendocri...

Por Dromain, Clarisse, Loaiza‐Bonilla, Arturo, Mirakhur, Beloo, Beveridge, Thomas J.R., Fojo, Antonio Tito
Publicado no Oncologist (2021)

Optimization of contrast-enhanced spectral mammography depending on clinical indication

Por Dromain, Clarisse, Canale, Sandra, Saab-Puong, Sylvie, Carton, Ann-Katherine, Muller, Serge, Fallenberg, Eva Maria
Publicado no J Med Imaging (Bellingham) (2014)

Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors

Por Dromain, Clarisse, Pavel, Marianne E., Ruszniewski, Philippe, Langley, Alison, Massien, Christine, Baudin, Eric, Caplin, Martyn E.
Publicado no BMC Cancer (2019)

Dual-energy contrast-enhanced digital mammography: initial clinical results of a multireader, multicase study

Por Dromain, Clarisse, Thibault, Fabienne, Diekmann, Felix, Fallenberg, Eva M, Jong, Roberta A, Koomen, Marcia, Hendrick, R Edward, Tardivon, Anne, Toledano, Alicia
Publicado em 2012

Tumor Growth Rate (TGR) is an early indicator of anti-tumor drug activity in phase I clinical trials

Por Ferté, Charles, Fernandez, Marianna, Hollebecque, Antoine, Koscielny, Serge, Levy, Antonin, Massard, Christophe, Balheda, Rastislav, Bot, Brian, Gomez-Roca, Carlos, Dromain, Clarisse, Ammari, Samy, Soria, Jean-Charles
Publicado em 2013

Efficacy, Safety, and Biomarkers of Single-Agent Bevacizumab Therapy in Patients with Advanced Hepatocellular Carcinoma

Por Boige, Valérie, Malka, David, Bourredjem, Abderrahmane, Dromain, Clarisse, Baey, Charlotte, Jacques, Nathalie, Pignon, Jean-Pierre, Vimond, Nadege, Bouvet-Forteau, Nathalie, De Baere, Thierry, Ducreux, Michel, Farace, Françoise
Publicado em 2012

Lessons from a multicentre retrospective study of peptide receptor radionuclide therapy combined with lanreotide for neuroendocrine tumours: a need for standardised practice

Por Prasad, Vikas, Srirajaskanthan, Raj, Toumpanakis, Christos, Grana, Chiara Maria, Baldari, Sergio, Shah, Tahir, Lamarca, Angela, Courbon, Frédéric, Scheidhauer, Klemens, Baudin, Eric, Truong Thanh, Xuan-Mai, Houchard, Aude, Dromain, Clarisse, Bodei, Lisa
Publicado no Eur J Nucl Med Mol Imaging (2020)

Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy – a...

Por Boilève, Alice, Maillard, Aline, Wagner, Mathilde, Dromain, Clarisse, Laurent, Christophe, Dupont Bierre, Eric, Le Sourd, Samuel, Audemar, Franck, Ulusakarya, Ayhan, Guerin-Meyer, Veronique, Smisth, Denis, Pezzella, Veronica, De Baere, Thierry, Goere, Diane, Gelli, Maximiliano, Taieb, Julien, Boige, Valérie
Publicado no BMC Cancer (2020)

Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients’ Outcome in Neuroendocrine Tumors (NET)—The GREPONET Study

Por Lamarca, Angela, Crona, Joakim, Ronot, Maxime, Opalinska, Marta, Lopez Lopez, Carlos, Pezzutti, Daniela, Najran, Pavan, Carvhalo, Luciana, Franca Bezerra, Regis Otaviano, Borg, Philip, Vietti Violi, Naik, Vidal Trueba, Hector, de Mestier, Louis, Schaefer, Niklaus, Sundin, Anders, Costa, Frederico, Pavel, Marianne, Dromain, Clarisse
Publicado no Oncologist (2019)